Fig. 1S
1 H NMR spectrum (600 MHz, CDCl 3 ) of pungiolide D (1).
Fig. 2S
13 C NMR spectrum (150 MHz, CDCl 3 ) of pungiolide D (1).
Fig. 3S
1 H-1 H COSY of pungiolide D (1).
Fig. 4S
HSQC of pungiolide D (1).
Fig. 5S
HMBC of pungiolide D (1).
Fig. 6S
NOESY of pungiolide D (1).
Fig. 7S
1 H NMR spectrum (600 MHz, CDCl 3 ) of pungiolide E (2).
Fig. 8S
13 C NMR spectrum (150 MHz, CDCl 3 ) of pungiolide E (2).
Fig. 9S
1 H-1 H COSY of pungiolide E (2).
Fig. 10S HSQC of pungiolide E (2).

Fig. 11S HMBC of pungiolide E (2).
Fig. 12S NOESY of pungiolide E (2).
Fig. 13S
1 H NMR spectrum (600 MHz, CDCl 3 ) of 8-epi-xanthatin-1α, 5α-epoxide (3).
Fig. 14S
13 C NMR spectrum (150 MHz, CDCl 3 ) of 8-epi-xanthatin-1α, 5α-epoxide (3).
Fig. 15S
HSQC of 8-epi-xanthatin-1α, 5α-epoxide (3).
Fig. 16S
HMBC of 8-epi-xanthatin-1α, 5α-epoxide (3).
Fig. 17S
NOESY of 8-epi-xanthatin-1α, 5α-epoxide (3).
Fig. 18S
1 H NMR spectrum (600 MHz, CDCl 3 ) of 1β-hydroxyl-5α-chloro-8-epi-xanthatin (4).
Fig. 19S
13 C NMR spectrum (150 MHz, CDCl 3 ) of 1β-hydroxyl-5α-chloro-8-epi-xanthatin (4).
Fig. 20S
HSQC of 1β-hydroxyl-5α-chloro-8-epi-xanthatin (4).
Fig. 21S
HMBC of 1β-hydroxyl-5α-chloro-8-epi-xanthatin (4).
Fig. 22S
NOESY of 1β-hydroxyl-5α-chloro-8-epi-xanthatin (4).
